AUS
NZ
UK
CA
USA
IND
ASX shares are wrapping up the week on a strong note, with the S&P/ASX 200 Index enjoying a robust session on Thursday. The benchmark index surged by 0.99% to reach 7,896.90 points.
Several ASX shares stand out today, exhibiting notable gains. Here's a closer look at three of them and the reasons behind their upward momentum:
Mesoblast Ltd (ASX: MSB)
Mesoblast's share price soared by an additional 12.12% to 56 cents. Investors rushed to acquire shares of this biotechnology company following a significant announcement related to its remestemcel-L product candidate. Mesoblast disclosed that the US Food and Drug Administration (FDA) has provided guidance indicating that there should be sufficient results to support the submission of the company's proposed Biologics License Application (BLA) for its stem cell therapy. This therapy targets the treatment of paediatric patients with steroid-refractory acute graft versus host disease.
Newmont Corporation (ASX: NEM)
Newmont's share price climbed by over 3.29% to AU$53.71. This increase follows another uptick in the gold price fueled by optimism surrounding potential rate cuts. Newmont is not the only beneficiary in the gold sector today, as numerous gold miners are witnessing substantial gains. Consequently, the S&P/ASX All Ordinaries Gold Index surged by 2.6% this afternoon.
Pilbara Minerals Ltd (ASX: PLS)
Pilbara Minerals observed a 2.31% uptick in its share price, reaching AU$3.83 apiece. Despite the absence of any news from the lithium miner today, it's noteworthy that most ASX lithium stocks are experiencing strong upward movement on Thursday. This surge seems to be influenced by a particularly bullish session for lithium stocks on Wall Street overnight.
The market's strong performance today underscores the resilience and potential of these ASX-listed companies, driven by positive developments and sector-wide momentum.
